p73 is over-expressed in vulval cancer principally as the Δ2 isoform

被引:43
作者
O'Nions, J
Brooks, LA
Sullivan, A
Bell, A
Dunne, B
Rozycka, M
Reddy, A
Tidy, JA
Evans, D
Farrell, PJ
Evans, A
Gasco, M
Gusterson, B
Crook, T
机构
[1] St Marys Hosp, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England
[2] Univ Glasgow, Western Infirm, Dept Pathol, Glasgow G11 6NT, Lanark, Scotland
[3] Univ London Kings Coll, Sch Med & Dent, Dept Mol Med, London SE5, England
[4] Univ Sheffield, No Gen Hosp, Dept Gynaecol Oncol, Sheffield S5 7AU, S Yorkshire, England
[5] St Marys Hosp, Sch Med, Dept Histopathol, London W2, England
[6] Poole Hosp NHS Trust, Dept Surg, Poole, Dorset, England
[7] Azienda Osped S Croce & Carle, UO Oncol Med, I-12100 Cuneo, Italy
关键词
vulval cancer; HPV; p73;
D O I
10.1054/bjoc.2001.2138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p73 was studied in squamous cancers and precursor lesions of the vulva. Over-expression of p73 occurred commonly in both human papillomavirus (HPV)-positive and -negative squamous cell cancers (SCC) and high-grade premalignant lesions. Whereas expression in normal vulval epithelium was detected only in the basal and supra-basal layers, expression in neoplastic epithelium increased with grade of neoplasia, being maximal at both protein and RNA levels in SCC. p73 Delta2 was the principal over-expressed isoform in the majority of cases of vulval SCC and often the sole form expressed in SCC. Over-expression of p73 was associated with expression of HPV-encoded E7 or with hypermethylation or mutation of p16(INK4a) in HPV-negative cases. There was a close correlation between expression of p73 and p14(ARF) in cancers with loss of p53 function. The frequent over-expression of p73 Delta2 in neoplastic but not normal vulval epithelium, and its co-ordinate deregulation with other E2F-1 responsive genes suggests a role in the oncogenic process. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1551 / 1556
页数:6
相关论文
共 28 条
[1]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[2]  
Brooks LA, 2000, CANCER RES, V60, P6875
[3]  
Chi SG, 1999, CANCER RES, V59, P2791
[4]  
Corn PG, 1999, CANCER RES, V59, P3352
[5]   CARCINOMA OF THE VULVA - EPIDEMIOLOGY AND PATHOGENESIS [J].
CRUM, CP .
OBSTETRICS AND GYNECOLOGY, 1992, 79 (03) :448-454
[6]   p63 and p73 transactivate differentiation gene promoters in human keratinocytes [J].
De Laurenzi, V ;
Rossi, A ;
Terrinoni, A ;
Barcaroli, D ;
Levrero, M ;
Costanzo, A ;
Knight, RA ;
Guerrieri, P ;
Melino, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) :342-346
[7]   Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768
[8]   Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53 [J].
Fillippovich, I ;
Sorokina, N ;
Gatei, M ;
Haupt, Y ;
Hobson, K ;
Moallem, E ;
Spring, K ;
Mould, M ;
McGuckin, MA ;
Lavin, MF ;
Khanna, KK .
ONCOGENE, 2001, 20 (04) :514-522
[9]  
Gazzeri S, 1998, CANCER RES, V58, P3926
[10]  
GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531